Despite all the challenges of moving the 2020 National Lymphedema Network (NLN) Conference online, the virtual event was an impressive industry success, and we were thrilled with the results!
Gerry Makoid, our president & CEO, appeared for interviews on Comcast’s “Money Matters” and RVNTV’s “The Advocates.” Topics discussed include the history of our company, business and manufacturing, and the healthcare conditions our products treat daily.
AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema as well as venous disorders, today announced it has received trademark registration from the United States Patent and Trademark Office (USPTO) for its company and brand name, “AIROS”.
AIROS Medical recently attended the Symposium for Advanced Wound Care’s (SAWC) Fall conference in Las Vegas, held from November 2-4. The event was the first public launch of AIROS’ new compression therapy device and garment line. Thousands of wound care professionals, including nurses, physicians, and administrative personnel, as well as podiatrists, physical therapists, and other […]
AIROS Medical is excited to announce availability of its line of compression therapy devices, including the AIROS 6 Sequential Compression Device, the AIROS 8 Sequential Compression Device, and the devices’ accessory compression garment line.
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced that the Pricing, Data, Analysis, and Coding (PDAC) contractor for Center for Medicare & Medicaid Services (CMS) has approved Healthcare Common Procedure Coding System (HCPCS) codes for the AIROS 6 and AIROS 8 devices and their respective accessories.
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced it has received two 510(k) regulatory clearances to market medical devices from the U.S. Food and Drug Administration (FDA).